<ul>
	<li>Nintedanib is indicated in adults for the treatment of Idiopathic Pulmonary Fibrosis (IPF).</li>
	<li>Nintedanib is indicated in adults for the treatment of chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype.</li>
	<li>Nintedanib is indicated in adults for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD).</li>
	<li>Nintedanib is indicated in combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or locally recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumor histology after first-line chemotherapy.</li>
</ul>